UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors

The European respiratory journal, 2017-09, Vol.50 (3), p.1602425-1602425

2017

Volltextzugriff (PDF)

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

Chest, 2014-11, Vol.146 (5), p.1274-1285

2014

Volltextzugriff (PDF)

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

PloS one, 2021-01, Vol.16 (1), p.e0245752-e0245752

2021

Volltextzugriff (PDF)

Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial

The lancet respiratory medicine, 2016-05, Vol.4 (5), p.372-380

2016

Volltextzugriff (PDF)

Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial

BMC cardiovascular disorders, 2017-09, Vol.17 (1), p.239-239, Article 239

2017

Volltextzugriff (PDF)

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial

The lancet respiratory medicine, 2016-05, Vol.4 (5), p.361-371

2016

Volltextzugriff (PDF)

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

PloS one, 2018-03, Vol.13 (3), p.e0193226-e0193226

2018

Volltextzugriff (PDF)

The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension

BMC cardiovascular disorders, 2019-06, Vol.19 (1), p.157-157, Article 157

2019

Volltextzugriff (PDF)

Prediction Score for persisting perfusion defects after pulmonary embolism

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2020-12, Vol.164 (4), p.394-400

2020

Volltextzugriff (PDF)

The impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension - results of a retrospective clinical registry

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2021-06, Vol.165 (2), p.157-161

2021

Volltextzugriff (PDF)

Computed tomography angiographic parameters of pulmonary artery as prognostic factors of residual pulmonary hypertension after pulmonary endarterectomy

Journal of international medical research, 2021-03, Vol.49 (3), p.3000605211002024-3000605211002024

2021

Volltextzugriff (PDF)

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension

Chest, 2017-01, Vol.151 (1), p.106-118

2017

Volltextzugriff (PDF)

PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

Orphanet journal of rare diseases, 2021-05, Vol.16 (1), p.196-196, Article 196

2021

Volltextzugriff (PDF)

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications

Medicina (Kaunas, Lithuania), 2022-10, Vol.58 (11), p.1538

2022

Volltextzugriff (PDF)

The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension

Clinical and applied thrombosis/hemostasis, 2024-01, Vol.30, p.10760296241271369

2024

Volltextzugriff (PDF)

Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)

Pulmonary circulation, 2020-07, Vol.10 (3), p.1-10

2020

Volltextzugriff (PDF)

Reperfusion after pulmonary embolism - long-term follow-up, risk factors, clinical impact

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 2018-06, Vol.162 (2), p.121-126

2018

Volltextzugriff (PDF)

Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2022, 11 , 6189

Journal of clinical medicine, 2023-06, Vol.12 (12), p.3939

2023

Volltextzugriff (PDF)

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil

Pulmonary circulation, 2023-07, Vol.13 (3), p.e12274-e12274

2023

Volltextzugriff (PDF)

Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic

Pulmonary circulation, 2022-01, Vol.12 (1), p.e12038-n/a

2022

Volltextzugriff (PDF)

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

BMC pulmonary medicine, 2017-12, Vol.17 (1), p.216-216, Article 216

2017

Volltextzugriff (PDF)

Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension

Journal of clinical medicine, 2022-10, Vol.11 (20), p.6189

2022

Volltextzugriff (PDF)

Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice

Pulmonary circulation, 2020-01, Vol.10 (1), p.1-11

2020

Volltextzugriff (PDF)

The significance of risk stratification in pulmonary arterial hypertension

Intervenční a akutní kardiologie, 2019-11, Vol.18 (Suppl A), p.26-29

Jansa, Pavel

2019

Volltextzugriff (PDF)

From venous thromboembolism to chronic thromboembolic pulmonary disease

Intervenční a akutní kardiologie, 2023-05, Vol.22 (2), p.70-73

2023

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(112)
Tagungsberichte
(5)

Sprache

Englisch
(115)
Tschechisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(61)
Humans
(39)
Female
(29)
Male
(29)
Cardiovascular System & Cardiology
(28)
Middle Aged
(27)
Cardiac & Cardiovascular Systems
(26)
Aged
(22)
Pulmonary Hypertension
(22)
Treatment Outcome
(20)
Adult
(19)
Respiratory System
(18)
Hypertension, Pulmonary - Drug Therapy
(16)
Pulmonary Arterial Hypertension
(14)
Hypertension, Pulmonary - Physiopathology
(12)
Chronic Thromboembolic Pulmonary Hypertension
(11)
Double-Blind Method
(11)
Hypertension
(11)
Pulmonary/respiratory
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial

Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial

Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension

Prediction Score for persisting perfusion defects after pulmonary embolism

The impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension - results of a retrospective clinical registry

Computed tomography angiographic parameters of pulmonary artery as prognostic factors of residual pulmonary hypertension after pulmonary endarterectomy

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension

PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications

The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension

Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)

Reperfusion after pulmonary embolism - long-term follow-up, risk factors, clinical impact

Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2022, 11 , 6189

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil

Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension

Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice

The significance of risk stratification in pulmonary arterial hypertension

From venous thromboembolism to chronic thromboembolic pulmonary disease

Aktive Filter

Suchergebnisse filtern